The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

Abstract excerpt

as a cardiac fibroblast-enriched super-enhancer-associated lncRNA that represents an attractive therapeutic target to reduce the pathological development of cardiac fibrosis in response to MI and prevent adverse remodeling in the damaged heart.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related molecular mechanisms research
• Share to Cardiac Fibrosis and Remodeling
• Share to Cardiac Valve Diseases and Treatments